Provided by Tiger Trade Technology Pte. Ltd.

China Resources Related

942.579
+8.4920.91%
Number of Gainers:6
Number of Losers:1
Number of Flat:- -
PE:- -
High:953.657
Open:934.662
Low:934.662
Close:934.088
Volume:67.12M
Turnover:1.30B
Market Cap:493.34B
Float Cap:493.33B

Loading ...

Morgan Stanley Trims China Resources Beer Target to HK$30, Maintains Overweight Stance

Deep News
·
1 hour ago

Record-Breaking Demand: China Res Land's Hong Kong Project Sets New Benchmark with 47,000+ Registrations

Deep News
·
3 hours ago

China Resources Building Materials Technology Holdings (SEHK:1313) Stock Sinks Deeper Into Losses

Simply Wall St.
·
7 hours ago

China Resources Pharmaceutical Group Says HY Revenue RMB 1.93 Billion for CR Jiangzhong

Reuters
·
Aug 21

China Resources Building Materials Technology Posts HY Loss Attributable of Rmb441.2 MLN

Reuters
·
Aug 21

China Resources Building Materials H1 Revenue Falls on Lower Cement and Building Materials Demand

Reuters
·
Aug 21

CR Building Materials Technology Reports Interim Loss Amid Revenue Decline

Stock News
·
Aug 21

China Resources Building Materials Declares Interim Dividend of HKD 0.014 a Share

Reuters
·
Aug 21

China Resources Building Materials Technology Holdings H1 Revenue RMB 8,636 Million

THOMSON REUTERS
·
Aug 21

China Resources Building Materials Technology Holdings H1 Net Income Attributable RMB -441.2 Million

THOMSON REUTERS
·
Aug 21

China Resources Pharma Reports Interim Results: Subsidiary Net Profit Dips Nearly 8%

Stock News
·
Aug 21

China Resources Pharmaceutical Group - Six-Month Revenue RMB 1.64 Bln, Down 50.97% for Kpc Pharmaceuticals

THOMSON REUTERS
·
Aug 21

CR Pharma Reports 4.91B Yuan Net Profit for Jiangzhong Unit in First Half, Down 5.92%

Stock News
·
Aug 21

China Resources Pharmaceutical - Cr Jiangzhong Proposed to Distribute Cash Dividend of RMB5 for Every 10 Shares

THOMSON REUTERS
·
Aug 21

China Resources Pharmaceutical Group - H1 2026 Revenue Down 2.03% to RMB 4.20 Bln for Tasly Pharmaceutical

THOMSON REUTERS
·
Aug 21

China Resources Gas Reports Interim Net Profit Decline at Chongqing Unit

Stock News
·
Aug 21

CR Boya Bio-Pharmaceutical, China Resources Pharmaceutical Subsidiary, Posts 77.28% Drop in H1 Net Profit Attributable to Shareholders to RMB 51.19 Million

Reuters
·
Aug 21

Morgan Stanley Trims China Resources Beer Target to HK$30, Keeps Overweight Stance

Stock News
·
Aug 21

China Resources Beer's Baijiu Business Likely to Only Recover in Longer Term

Dow Jones
·
Aug 21

Canada's Diamond Estates Q1 Revenue Falls on Lower Winery Shipments

Reuters
·
Aug 21